Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomized controlled trial
EURAMOS-1 investigators
Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review
333Citaten
(Scopus)
Vingerafdruk
Duik in de onderzoeksthema's van 'Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomized controlled trial'. Samen vormen ze een unieke vingerafdruk.